Traditional Medicinal Plants as a Source of Antituberculosis Drugs: A System Review

Traditional Medicinal Plants as a Source of Antituberculosis Drugs: A System Review

Medicinal plants are the chief components in the different oriental formulations in different traditional medical systems worldwide. As a thriving source of medicine, the medicinal plants with antituberculosis (TB) properties inspire the pharmacists to develop new drugs based on their active compone...

Full description

Bibliographic Details
Main Authors:	Yuhui Xu, Bowen Liang, Chengcheng Kong, Zhaogang Sun
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2021/9910365

Similar Items

Southeast Asian Medicinal Plants as a Potential Source of Antituberculosis Agent
by: Shuaibu Babaji Sanusi, et al.
Published: (2017-01-01)

Plants used in traditional medicine as sources of drugs
by: Gunnar Samuelsson
Published: (1987-01-01)

Acquired Resistance to Antituberculosis Drugs
by: Htin Lin Aung, et al.
Published: (2018-11-01)

Combination Effect of Antituberculosis Drugs and Ethanolic Extract of Selected Medicinal Plants against Multi-Drug Resistant Mycobacterium tuberculosis Isolates
by: Prabasiwi Nur Fauziyah, et al.
Published: (2017-03-01)

Antituberculosis drug-induced hepatotoxicity in children
by: Peter R. Donald
Published: (2011-06-01)

Seizures following Intoxication with a Common Antituberculosis Drug
by: Adnane Lahlou, et al.
Published: (2019-01-01)

Antituberculosis Drug-induced Hepatotoxicity in Pediatric Tuberculosis
by: Vycke Yunivita, et al.
Published: (2019-10-01)

Mycobacterium tuberculosis resistance to antituberculosis drugs in Mozambique
by: Germano Manuel Pires, et al.
Published: (2014-04-01)

Drug–drug interaction analysis: Antituberculosis drugs versus antiretroviral drugs
by: Won Sriwijitalai, et al.
Published: (2019-01-01)

Design and synthesis of antituberculosis compounds
by: ZOU Shun, et al.
Published: (2020-08-01)

Benefits of Therapeutic Drug Monitoring of First Line Antituberculosis Drugs
by: Prso K, et al.
Published: (2020-08-01)

Adverse reaction to antituberculosis drugs (ADRA). A reality in Bolivia
by: Mamani-Poma Augusto
Published: (2018-02-01)

Repurposing chlorpromazine and its metabolites for antituberculosis drug discovery
by: Kigondu, Elizabeth Victoria Mumbi
Published: (2016)

Aureolic Acid Group of Agents as Potential Antituberculosis Drugs
by: Julia Bespyatykh, et al.
Published: (2020-10-01)

Combined antiretroviral and antituberculosis drug resistance following incarceration
by: Katharine Elizabeth Stott, et al.
Published: (2013-09-01)

Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis Patients
by: Aliasghar Farazi, et al.
Published: (2014-01-01)

Risk factors associated with adverse reactions to antituberculosis drugs
by: Laíse Soares Oliveira Resende, et al.
Published: (2015-02-01)

Antituberculosis Drug Interactions with Membranes: A Biophysical Approach Applied to Bedaquiline
by: Marina Pinheiro, et al.
Published: (2019-10-01)

Antituberculosis Targeted Drug Delivery as a Potential Future Treatment Approach
by: Mohd Khairul Nizam Mazlan, et al.
Published: (2021-07-01)

Treatment of a Tuberculous Empyema with Simultaneous Oral and Intrapleural Antituberculosis Drugs
by: Richard Long, et al.
Published: (2008-01-01)

Preclinical pharmacokinetic evaluation of novel antimalarial and antituberculosis drug leads
by: Strydom, Natasha
Published: (2019)

New antituberculosis drugs: from clinical trial to programmatic use
by: Gina Gualano, et al.
Published: (2016-06-01)

Antituberculosis drugs and hepatotoxicity among hospitalized patients in Jos, Nigeria
by: Samson E Isa, et al.
Published: (2016-01-01)

Analysis on the clinical characters of optic neuritis caused by antituberculosis drugs
by: Yi-Luan Jian, et al.
Published: (2014-09-01)

Correlation between Antituberculosis Drug-Induced Hepatotoxicity and Patient’s Diseases
by: Yung-Chia Hsu, et al.
Published: (2010)

Patients Using Antituberculosis Drugs with Medications for Their Comorbidity to Cause Hepatotoxicity
by: Tzu-I Tang, et al.
Published: (2013)

PRECLINICAL STUDIES OF THE SPECIFIC ACTIVITY OF THE NEW ANTITUBERCULOSIS DRUG THIOZONIDE
by: I. V. Bocharova, et al.
Published: (2014-06-01)

Chinese Traditional Medicine NiuBeiXiaoHe (NBXH) Extracts Have the Function of Antituberculosis and Immune Recovery in BALB/c Mice
by: Yan Liang, et al.
Published: (2021-01-01)

Role of Drug Metabolic Enzymes and Transporters in Drug-Drug Interactions Between Antiretroviral and Antituberculosis Drugs
by: Md Masud Parvez, et al.
Published: (2018-04-01)

Cytokines in antituberculosis immunity
by: M V Zakharova, et al.
Published: (2009-12-01)

Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes
by: Qiang Su, et al.
Published: (2021-01-01)

TIPdb: A Database of Anticancer, Antiplatelet, and Antituberculosis Phytochemicals from Indigenous Plants in Taiwan
by: Ying-Chi Lin, et al.
Published: (2013-01-01)

Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
by: Oymak Sema F, et al.
Published: (2002-12-01)

Incidence and characteristics of antituberculosis drug-induced hepatotoxicity in children: a preliminary study
by: Bina Akura, et al.
Published: (2009-12-01)

In Vivo Modulation of Rat Liver Microsomal Cytochrome P450 Activity by Antimalarial, Anti-HIV, and Antituberculosis Plant Medicines
by: Regina Appiah-Opong PhD, et al.
Published: (2018-11-01)

Permeability of active ingredients of cannabis and possibility for further antituberculosis drug development
by: Pathum Sookaromdee, et al.
Published: (2021-01-01)

USE OF CHOLUDEXAN TO TREAT ANTITUBERCULOSIS DRUG-INDUCED LIVER INJURY 1
by: A. V. Mordyk, et al.
Published: (2014-02-01)

Naringenin mitigates antituberculosis drugs induced hepatic and renal injury in rats
by: Nisha Sahu, et al.
Published: (2020-01-01)

Toxicidad hepática por medicamentos antituberculosos Hepatotoxicity induced by antituberculosis drugs
by: Isabel Eugenia Escobar Toledo, et al.
Published: (2008-01-01)

THE INCIDENCE OF MYCOBACTERIUM TUBERCULOSIS INFECTIONS AND RESISTANCE TO ANTITUBERCULOSIS DRUGS IN GIURGIU POPULATION
by: Ionica Deliu, et al.
Published: (2014-11-01)